Experiments
Searchable full-text extractions: founding hypothesis, core claims, experimental setups, key results and statistics — pulled out of each paper as structure. Search a cell line, an assay or an entity (e.g. HUH7) and find every paper that worked with it. This corpus stands on its own: most entries carry no reproduction assessment (yet).
-
Has reproduction · 69
JunB Is Critical for Survival of T Helper Cells.
PMID 35837408 · PMC9273772 · Frontiers in immunology · 2022 · 7 claims · 7 setups
JunB is required for clonal expansion of Th1, Th2, and Th17 cells
-
Full-text index only
Integrative miRNA-mRNA Network and Molecular Dynamics-Based Identification of Therapeutic Candidates for Paroxysmal Nocturnal Hemoglobinuria.
PMID 41599741 · PMC12845513 · Pharmaceuticals (Basel, Switzerland) · 2026 · 8 claims · 8 setups
A PIGA-knockout (PIGA-KO) THP-1 cell model was successfully established using CRISPR/Cas9 RNP technology as a PNH model
-
Full-text index only
Molecular interactome of HNRNPU reveals regulatory networks in neuronal differentiation and DNA methylation.
PMID 41674383 · PMC12895067 · Nucleic acids research · 2026 · 7 claims · 8 setups
HNRNPU forms extensive protein networks including an association with the mammalian SWI/SNF chromatin-remodeling complex
-
Full-text index only
Characterization of Phytoene Desaturase Knockout Carotenoid-Deficient Microalgal Mutants Generated by Cas9-Ribonucleoprotein Complexes.
PMID 41757451 · PMC12947057 · Physiologia plantarum · 2026 · 8 claims · 8 setups
Cas9-ribonucleoprotein (RNP) complexes with dual sgRNAs targeting PDS exon 1 and a donor DNA sequence successfully generated multiple white PDS-knockout Chlamydomonas transformants
-
Full-text index only
Omics-aided design genome editing strategy for challenging human immortalized cell models.
PMID 41678468 · PMC12900285 · PloS one · 2026 · 6 claims · 4 setups
Omics profiling identifies bottlenecks associated with poor precise KI efficiency in hard-to-engineer cells
-
Full-text index only
Vitamin C Conditioning Generates Tumor-Targeting CAR T Cells with Superior Cytotoxicity and Fitness in a Posttransplant Lymphoproliferative Disorder Tumor Model.
PMID 41416402 · PMC13136873 · Molecular cancer therapeutics · 2026 · 8 claims · 8 setups
VitC conditioning enhances transduction efficiency and proliferative capacity, yielding a higher yield of CD4+ and CD8+ CAR19-Ts